New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Trulieve Cannabis Corp.
TRUL.CN
Shape
US Flag

CNQ

Unprofitable

EPS improving

Unprofitable

EPS improving

3B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

3B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

16.10CAD
Shape0.05 ( 0.31%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-49%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

19%

Quote Panel

Shape
Updated October 15, 2024
1W 0.81 % 1M 4.88 % 3M 15.47 % 1Y 136.02 %

Key Metrics

Shape
  • Market Cap

    3.01B


  • Shares Outstanding

    187.09M


  • Share in Float

    177.67M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    16.1


  • Average Volume

    122008


  • Beta

    1.432


  • Range

    5.22-20.0


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.trulieve.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.87x

P/S Ratio

1.61x

P/B Ratio

0.6

Debt/Equity

-8.1%

Net Margin

$-0.7

EPS

How TRUL.CN compares to sector?

P/E Ratio

Relative Strength

Shape

TRUL.CN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape461%

2025-Revenue

$0.26

Shape-305%

2025-EPS

$727M

Shape647%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-88%

0.02
vs 0.17

Q4.22

arrow
arrow

N/A

-0.41
vs -0.46

Q1.23

arrow
arrow

N/A

-0.34
vs -0.17

Q2.23

arrow
arrow

N/A

-0.51
vs -0.12

Q3.23

arrow
arrow

N/A

-0.14
vs 0.02

Q4.23

arrow
arrow

N/A

-0.18
vs -0.41

Q1.24

arrow
arrow

N/A

-0.12
vs -0.34

Q2.24

arrow
arrow

N/A

-0.06
vs -0.51

Q3.24

arrow
arrow

N/A

-0.10
vs -0.14

Q4.24

arrow
arrow

N/A

-0.09
vs -0.18

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+34%

300.8M  vs 224.1M

Q4.22

arrow
arrow

-1%

302.2M  vs 305.3M

Q1.23

arrow
arrow

-9%

289.1M  vs 318.3M

Q2.23

arrow
arrow

-12%

281.8M  vs 320.3M

Q3.23

arrow
arrow

-9%

275.2M  vs 300.8M

Q4.23

arrow
arrow

-5%

287M  vs 302.2M

Q1.24

arrow
arrow

+3%

297.6M  vs 289.1M

Q2.24

arrow
arrow

+8%

303.4M  vs 281.8M

Q3.24

arrow
arrow

+43%

393.8M  vs 275.2M

Q4.24

arrow
arrow

+44%

413.3M  vs 287M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-4%

-0.04
vs -0.01

Q4.22

arrow
arrow

-4%

-0.04
vs -0.04

Q1.23

arrow
arrow

-4%

-0.04
vs -0.04

Q2.23

arrow
arrow

-28%

-0.28
vs -0.04

Q3.23

arrow
arrow

-2%

-0.02
vs -0.28

Q4.23

arrow
arrow

-2%

-0.02
vs -0.02

Q1.24

arrow
arrow

-2%

-0.02
vs -0.02

Q2.24

arrow
arrow

-1%

-0.01
vs -0.02

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News